methods for detecting the presence of at least one pathogenic bordetella species and selecting a patient exhibiting pertussis-like symptoms, and kit for detecting the presence of at least one pathogenic bordetella species.

摘要

The present disclosure relates to methods for determining whether a patient exhibiting pertussis-like symptoms will benefit from treatment with therapeutic agents that inhibit bordetella holmesii. These methods are based on the detection of bordetella pertussis, bordetella parapertussis and bordetella holmesii in a biological sample by assessing the presence of the target repeating elements is481, is1001 and his1001, respectively. Kits for use in practicing the methods are also provided.